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Objective: Flavonoids are naturally occurring compounds widely distributed in plants, which have
hypoglycemic potential and have been described as glucosidase inhibitors. This study evaluated the
effect of ﬂavonoids on intestinal glucosidase activity after in vivo and in vitro treatment.
Methods: For the in vivo studies animals received quercetin by gavage and for the in vitro assays
a segment of the small intestine was used. To obtain the oral glucose tolerance curve fasted normal
rats were loaded with glucose plus ﬂavonoids. The glycemia was measured by the glucose oxidase
method.
Results: Quercetin reduced the effect of sucrase and maltase in the in vivo and in vitro treatments. It
was observed in the in vitro studies that the maximum inhibitory effect of kaempferitrin was
around 23% for maltase activity. Also, for the sucrose substrate the speciﬁc enzyme activity was
signiﬁcantly decreased. Aglycone, ﬂavonoids, and kaempferol decreased signiﬁcantly the maltase
activity at all concentrations assayed. Finally, rutin reduced maltase-speciﬁc activity at all
concentrations studied. According to the oral glucose tolerance curve, rutin reduced the serum
glucose levels at 15, 30, and 60 min when administered by oral gavage 30 min before glucose
overload in rats.
Conclusion: Based on these results, we can conclude that disaccharidases are targets of ﬂavonoids
in the regulation of glucose absorption and consequently glucose homeostasis.
 2011 Elsevier Inc. Open access under the Elsevier OA license.Introduction
Flavonoids are naturally occurring phenolic compounds that
are widely distributed in plants and some of them have been
described as glucosidase inhibitors [1,2]. Glucosidase inhibitors
are potential agents for diabetes therapy since glucosidases are
involved in several important and relevant biological processes
[3]. Acarbose, the ﬁrst a-glucosidase inhibitor to be identiﬁed, is
currently used for the treatment of type 2 diabetes [4].
Diabetes mellitus is a complex metabolic disorder in the
endocrine system characterized by abnormalities in insulin
secretion and/or insulin action that leads to progressive deteri-
oration of glucose tolerance and causes hyperglycemia. Thisx: þ55-48.3721.96.72.
ilva).
evier OA license.disease is a major public health problem worldwide and is
rapidly becomingmore common [1,5]. One therapeutic approach
to decreasing postprandial hyperglycemia is to retard the
absorption of glucose via inhibition of carbohydrate-hydrolyzing
enzymes, such as glucosidase, in the intestine [6]. The glucosi-
dase enzymes are located in the brush border of the small
intestine and are required for the breakdown of carbohydrates
before monosaccharide absorption. The alpha-glucosidase
inhibitors delay the absorption of ingested carbohydrates,
reducing the postprandial glycemia and insulin peaks [7].
Flavonoids are potential antidiabetic agents because they exert
multiple actions that are both hypoglycemic (insulinomimetic
action) and antihyperglycemic (insulin secretagogue) [1,2]. Our
group has investigated the effects of different classes of ﬂavonoids
on glucose control in hyperglycemic rats (glucose overloaded) and
in chemically induced diabetic rats. In these studies it was
Fig. 1. (A) Basal speciﬁc activity of maltase, sucrase, and lactase in the duodenum,
jejunum, and ileum from the small intestine of rats. Signiﬁcant at *P  0.05
compared to duodenum sucrase group; **P  0.01 compared to duodenum lactase
group; ###P  0.001 compared to jejunum sucrase and lactase group; þþþP  0.001
compared to ileum sucrase and lactase group. (B) In vitro time course of speciﬁc
activity of maltase, sucrase, and lactase in the duodenal portion of rat intestine.
Values are expressed as mean  SEM; n ¼ 6 for each group.
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feritrin) and kaempferol-3-neohesperidoside act throughmultiple
sites, constituting strong evidence for their insulinomimetic role in
assuring glucose homeostasis [8–12]. We also showed that api
genin-6-C-(2"-O-a-L-rhamnopyranosyl)-b-L-fucopyranoside and
apigenin-6-C-b-L-fucopyranoside can act either as insulin-
secretagogues or as insulinomimetic agents [13,14]. Thus, it
seems clear that ﬂavonoids can act through a number of tissues to
regulate serum glucose homeostasis. Based on these ﬁndings, the
aim of this study was to investigate the effects of quercetin,
kaempferitrin, rutin, and kaempferol on in vivo and/or in vitro
intestinal glucosidase activity.
Materials and methods
Materials
Dehydrated quercetin was purchased from Sigma-Aldrich Chemical Co. (St.
Louis, MO, USA). NaOH, D(þ)-monohydrated maltose and NaCl were acquired
from Vetec (Duque de Caxias, Rio de Janeiro, Brazil); sucrose, lactose, and maleic
acid were acquired fromNuclear (Diadema, S~ao Paulo, Brazil), and the Glucose-PP
kit was acquired from Analisa (Belo Horizonte, Minas Gerais, Brazil). The
kaempferitrin, kaempferol, and rutin used in this study were available from our
previous studies [15,16,17].
Experimental animals
Male Wistar rats, 50-55 day old and weighing around 180-200 g, were used.
The animals were housed in cages (six animals per cage) and kept in an air-
conditioned room (approximately 21C) with controlled lighting (photoperiod
of 12-h light and 12-h darkness). Pelleted food (Bio Base, Aguas Frias, SC, Brazil)
and water were available to the rats ad libitum until the start of the experiments.
All the animals were carefully monitored and maintained in accordance with the
ethical recommendations of the Brazilian Veterinary-Medicine Council and the
Brazilian College of Animal Experimentation.
Rats were divided into ﬁve groups of six animals each: group I, control; group
II, treated in vivo with quercetin 50 and 100 mg/kg (po; corresponding to 0.06
and 0.140M, respectively) for 0, 30, and 60min; group III, duodenal homogenates
were incubated in vitro with quercetin, kaempferitrin, rutin, or kaempferol at
different concentrations (3.125, 6.25, 12.5, 25, 50, 100, 200, and 400 mM), for 5
min; group IV, treated in vitro with quercetin at 0.06 M for 5 min; group V,
treated in vivowith rutin (50mg/kg) 30min before or at the same time as glucose
(4 g/kg; 8.9 M), by oral gavage. Blood was collected at 0, 15, 30, 60, and 180 min
for serum glucose measurements. Rats were fasted for 16 h before a single oral
administration of quercetin by gavage for in vivo treatment or before euthanasia
for in vitro treatment with quercetin, kaempferitrin, rutin, or kaempferol [9].
Disaccharidase extraction and assays
A segment of the small intestine was removed, washed in 0.9% NaCl solution,
dried on ﬁlter paper, weighed, trimmed, and homogenized (300 rpm) with 0.9%
NaCl (400 mg of duodenum per milliliter) for 1 min at 4C. The resulting extract
was centrifuged at 8000 rpm for 8 min. The supernatant was used for the
measurement of in vitro and in vivo maltase, sucrase, and lactase activities and
protein determination.
Maltase (EC 3.2.1.20), lactase (EC 3.2.1.23), and sucrase (EC 3.2.1.48) activities
were determined using a glucose diagnosis kit based on the glucose oxidase
reagent. For determination of disaccharidase activity in group I (control) and
group II, the incubation system containing 0.112 mM of sucrose, lactose, or
maltose dissolved in sodiummaleate buffer (pH 6.0) and the appropriate enzyme
extract volume was incubated for 10 min at 37C [18]. At the end of this time, 1
mL of the color reagent solution containing glucose oxidase and peroxidase was
added and incubated at 37C for 10min. The absorbance was read at 500 nm, and
the activity calculationwas based on a glucose standard. For groups III and IV, the
homogenate was preincubated at 37C for 5 min, in the absence (control) or in
the presence of the ﬂavonoids quercetin, rutin, kaempferitrin, or kaempferol
(treated). Duodenum homogenates were then incubated at 37C for 5 min with
the substrate (corresponding to 0.056 mM of maltose, sucrose, or lactose).
One enzyme unit was deﬁned as the amount of enzyme that catalyzed the
release of 1 mmol of glucose per minute under the assay conditions. The speciﬁc
activity was deﬁned as enzyme activity per milligram of protein. Protein
concentration was determined by the method described in Lowry et al. [19],
using bovine serum albumin as the standard. The assays were performed in
duplicate and conducted along with appropriate controls.Determination of serum glucose levels
Blood samples from the tail vein were collected and centrifuged and the
serum was used to determine the glycemia by the glucose oxidase method [20].
Data and statistical analysis
Data were expressed as mean  SEM. One-way analysis of variance was
employed followed by Bonferroni’s post test, using GraphPad Software 3.01 for
Windows 95 (San Diego, CA, USA). Differences were considered to be signiﬁcant
at P  0.05.
Results
Basal speciﬁc activity of maltase, sucrase, and lactase in the
duodenum, jejunum, and ileum of rat small intestine
The basal in vitro activity of maltase, sucrase, and lactase was
measured in the duodenum, jejunum, and ileum of rat small
intestine. Figure 1A shows that although the activities of sucrase
and lactase were detected in all portions of the intestine assayed,
the activity of maltase was signiﬁcantly higher than both of them
in the duodenum, jejunum, and ileum. Figure 1B shows the time
course of maltase, sucrase, and lactase activities measured in the
duodenal homogenate. It can be seen that the activity decreased
from the basal level as a function of time and the highest activity
for all enzymes studied was detected after 5 min of in vitro
Fig. 2. In vivo effect of quercetin on speciﬁc activity of (A) sucrase and in vitro effect of quercetin on speciﬁc activity of (B) sucrase and (C, D) in vitro effect of quercetin on
speciﬁc activity of maltase in the duodenal portion of rat intestine. Values are expressed as mean  SEM; n ¼ 6. Signiﬁcant at ***P  0.01 compared to control group.
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subsequent in vitro tests on enzyme activity in the duodenal
portion of the small intestine.
In vivo and in vitro effect of quercetin on speciﬁc activity of
duodenal sucrase and maltase
In the present study we investigated the effect of quercetin
on intestinal disaccharidase enzymes at 30 and 60 min after
oral treatment, the same time used to study the basal activity of
disaccharidases on the substrate (Fig. 1A). Figure 2A illustrates
the inhibitory effect of quercetin at 50 and 100 mg/kg (0.06 and
0.140 mM, respectively) on sucrase activity after short- and long-
term in vivo treatment. However, this inhibitory effect was not
replicated in the case of maltase and lactase activities, at least
within the treatment periods studied (data not shown).
Surprisingly, a complete inhibitory effect of quercetin on
sucrase activity was detected in vitro when the concentration of
quercetin used in vivo (50 mg/kg¼ 0.06 M) was tested for 5 min(Fig. 2B). Based on this ﬁnding, a wide range of concentrations
was assayed to test the effect of the other ﬂavonoids on sucrase,
maltase, and lactase activities. Figure 2C shows a signiﬁcant
inhibitory effect of quercetin (3.125, 6.25, 12.5, 25, 100, 400 mM)
on the speciﬁc activity of duodenal maltase after 5 min of in
vitro incubation with this ﬂavonoid, and in Figure 2D the
inhibition of maltase activity in vitro was observed with quer-
cetin incubated for 5 min using the concentrations tested in
vivo (50 mg/kg ¼ 0.06 M).
In vitro effect of kaempferitrin and kaempferol on speciﬁc activity
of duodenal maltase and sucrase
Figure 3A shows a signiﬁcant inhibitory effect of kaemp-
feritrin (3.125, 6.25, 12.5, and 25 mM) on the speciﬁc activity of
duodenal maltase after 5 min of in vitro incubation with this
ﬂavonoid. The maximum inhibitory effect obtained with
kaempferitrin was around 23%. The doses of kaempferitrin
chosen for in vitro studies were calculated from that which
Fig. 3. In vitro effect of kaempferitrin on speciﬁc activity of (A) maltase, (B) sucrase, and in vitro effect of kaempferol on speciﬁc activity of (C) maltase in the duodenal portion
of rat intestine. Incubation ¼ 5 min. Values are expressed as mean  SEM; n ¼ 6 for each group. Signiﬁcant at *P  0.05, **P < 0.01 and ***P  0.001 compared to their
respective control group.
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the data presented in Figure 3A, acarbose (700 mM), the
well-known inhibitor of intestinal disaccharidases activity,
diminished maltase activity by around 50%. Also, the speciﬁc
activity of duodenal sucrase was signiﬁcantly diminished in thepresence of kaempferitrin (3.125, 6.25, 12.5, and 25 mM) by
a similar extent to that of maltase (Fig. 3B). However, the
speciﬁc activity of lactase was unaltered in the presence of this
ﬂavonoid (data not shown). The effect of kaempferol aglycone
on the speciﬁc activity of maltase in the intestinal homogenate
Fig. 4. In vitro effect of rutin on speciﬁc activity of (A) maltase in the duodenal portion of rat intestine. Incubation ¼ 5 min. Effect of rutin on oral glucose tolerance curve. (B)
Rutin by oral gavage 30 min before glucose loading in rats. (C) Rutin plus glucose by oral gavage at the same time. Values are expressed as mean  SEM; n ¼ 6. Signiﬁcant at
**P  0.01 and ***P  0.001 compared to their respective control group.
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had a signiﬁcant inhibitory effect on maltase activity at all
concentrations tested. This effect was around 20% for kaemp-
ferol, compared to the control group. The inhibitory effects of
kaempferol represent 48% of the effect of the powerful gluco-
sidase inhibitor acarbose, studied under the same experimental
conditions. However, kaempferol did not alter the sucrase and
lactase activities at any concentration studied (data not
shown).In vitro effect of rutin on speciﬁc activity of duodenal maltase and
on oral glucose tolerance curve
In this study, we observed that this O-glycoside reduced
speciﬁc activity of maltase at all concentrations studied (3.125,
6.25, 12.5, 25, 50, 100, 200, and 400 mM) after 5 min of in vitro
incubation when compared with the basal group (Fig. 4A). The
maximum effect of rutin was 55%, while that of acarbose was
56%. Furthermore, even with the lowest concentration of rutin,
the inhibitory effect on maltase activity was similar to that
observed for acarbose.
On the other hand, rutin did not affect the sucrase and
lactase activity at any concentration tested (data not shown).
The speciﬁcity of the action of rutin can be seen from the proﬁle
of the response in terms of the activities of the three enzymes
analyzed in the intestinal homogenate. It is clear that rutin hasa deﬁned target in the intestine, and the powerful effect of
rutin on maltase was corroborated by its signiﬁcant serum
glucose-lowering effect observed in the oral glucose tolerance
curve (Fig. 4B, C). Rutin (50 mg/kg) reduced serum glucose
levels at 15, 30, and 60 min when administered by oral gavage
30 min before glucose (4 g/kg; 8.9 M) overload in rats (Fig. 4B).
However, when rats were overloaded with glucose and treated
with rutin at the same time, no signiﬁcant difference in glucose
levels was detected (Fig. 4C).Discussion
Quercetin is one of the most common ﬂavonol aglycones and
is widespread in nature [1,2]. This ﬂavonoid activates hexokinase
and glucokinase [23] and inhibits both glycogen phosphorylase
a and b and hepatic glucose-6-phosphatase [24].
This signiﬁcant biological action of quercetin on sucrase
activity detected after in vivo treatment by oral gavage and in
vitro after a short period of incubation is in line with the quer-
cetin effect reported by Shimizu et al. [25], who demonstrated
a marked reduction in glucose absorption, when compared with
the control. In other reports it has been proposed that the
inhibitory effect of quercetin on glucose absorption is due to
competitive inhibition of the sodium-dependent glucose
transporter-1 [1,2]. Considering the results of our previous
D. Fontana Pereira et al. / Nutrition 27 (2011) 1161–11671166studies [10,12–14], these results verify multiple sites of action for
different ﬂavonoids in the modulation of glucose homeostasis.
Based on these ﬁndings, we decided to study the short-term
effects of the ﬂavonoids quercetin, kaempferitrin, rutin, and
kaempferol on duodenummaltase, sucrase, and lactase activities
and to compare the results with the known effect of acarbose on
a-glucosidases. It should be noted that to carry out these studies,
a kaempferitrin dose of 100 mg/kg (0.0294 mmol/kg) was used,
because this is the most efﬁcient in terms of reducing serum
glucose in diabetic rats, as previously reported by our laboratory
[9–15].
We have previously demonstrated that oral administration of
kaempferitrin led to a signiﬁcant hypoglycemic effect in normal
and alloxan-induced diabetic rats [9]. In addition, this compound
stimulates in vitro glucose uptake in a target tissue of insulin and
skeletal muscle [15]. More recently, we discussed that ﬂavonoids
regulate glucose homeostasis through a multitude of actions and
by a complex intracellular signaling dictated by the particular
structure of O- or C-glycosides or aglycone ﬂavonoids [1,2].
Additionally, ﬂavonoid action is dependent on the number, type,
and position of glycosyl residues on the natural compounds.
Speciﬁcally, for kaempferitrin, in previous studies we demon-
strated that skeletal muscle is a signiﬁcant target for the insuli-
nomimetic effect of this compound; however, other important
tissues in terms of glucose homeostasis, such as intestinal, were
not studied. Thus, to our knowledge, this is the ﬁrst time that
intestinal disaccharidase activity has been investigated in the
presence of kaempferitrin.
Among the reported biological properties of rutin are the anti-
hyperglycemic andhypoglycemic effects in diabetic rats [21,26,27],
an increase in insulin and C-peptide serum levels, a protective
effect on pancreatic b-cells, restoration of glycogen content and
hexokinase activity, and decreased glucose-6-phosphatase and
fructose-1,6-bisphosphatase activities [28].
Our results for the in vitro effect of quercetin and kaemp-
ferol on the speciﬁc activity of duodenal maltase are in line
with those reported by Matsui et al. [29], concerning the
inhibitory effects of kaempferol, chrysin, galangin, and luteolin
on a-glucosidase activity, observed in both in vitro and in vivo
studies on the absorption and metabolism of carbohydrates.
The putative inhibitory effects of some ﬂavonoids on a-gluco-
sidase activity were conﬁrmed by Kim et al. [30], who showed
that luteolin, amentoﬂavone, luteolin 7-O-glucoside, and
daidzein are strong inhibitors of glucosidases. Also, Andrade-
Cetto et al. [5] reported that ﬂavonoid-enriched extracts from
some Mexican plants efﬁciently inhibited a-glucosidase
activity and signiﬁcantly reduced serum-glucose levels in dia-
betic rats.Conclusions
Based on the results reported herein, it can be concluded that
disaccharidases are targets of ﬂavonoids in the regulation of
glucose absorption and consequently glucose homeostasis.
Rutin, a glycosylated ﬂavonoid, showed an acarbose-like inhibi-
tory effect on maltase activity and this was highly speciﬁc to
maltase. In addition, the effect of rutin in the intestine was
reinforced because this ﬂavonoid was able to reduce glycemia
when administered before glucose overload. Because it is evident
that multiple sites of action for ﬂavonoids can contribute
signiﬁcantly to the serum glucose balance, studies are underway
to investigate the molecular action of some selected ﬂavonoids
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